Editas Medicine Announces Poster Presentations at the European Society of Gene and Cell Therapy (ESGCT) 33rd Annual Congress and Participation in Upcoming Investor Conference

On October 14, 2026 Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, reported two poster presentations at the European Society of Gene and Cell Therapy (ESGCT) 33rd Annual Congress, to be held October 27-30, 2026, in Hamburg, Germany.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

European Society of Gene and Cell Therapy (ESGCT) Congress
Title: Novel targeted LNP delivery achieved in vivo CAR-T cell generation resulting in therapeutically relevant B-cell depletion
Session Date and Time: Wednesday, October 28, 2026, 1:30 – 3:30 p.m. CET
Session Title: Poster Session 1
Presenter: Harry An, Director, Process Development, Editas Medicine
Final Abstract Number: P0361

Title: Development of a configurable, GMP-ready manufacturing platform for targeted LNP therapeutics
Session Date and Time: Wednesday, October 28, 2026, 1:30 – 3:30 p.m. CET
Session Title: Poster Session 1
Presenter: Harry An, Director, Process Development, Editas Medicine
Final Abstract Number: P0781
Abstracts can be accessed on the conference website as they become available, and presentations will also be posted to the "Posters & Presentations" section of the Company’s website during the conferences.

In addition, management will participate in the following upcoming investor conference in November:

Guggenheim 3rd Annual Healthcare Innovation Conference
Format: Fireside Chat
Date and Time: November 10, 2026, 2:30 p.m. ET
Location: Boston, Massachusetts
To access the live webcast of Editas Medicine’s Fireside Chat, please visit the "Investors" section of the Company’s website at www.editasmedicine.com. An archived replay will be available for approximately 30 days following the event.

(Press release, Editas Medicine, OCT 14, 2026, View Source [SID1234673455])